Brueggemann Lioubov I, Mani Bharath K, Haick Jennifer, Byron Kenneth L
Department of Molecular Pharmacology & Therapeutics, Loyola University Chicago, USA.
J Vis Exp. 2012 Sep 14(67):e4263. doi: 10.3791/4263.
Contraction or relaxation of smooth muscle cells within the walls of resistance arteries determines the artery diameter and thereby controls flow of blood through the vessel and contributes to systemic blood pressure. The contraction process is regulated primarily by cytosolic calcium concentration (Ca(2+)), which is in turn controlled by a variety of ion transporters and channels. Ion channels are common intermediates in signal transduction pathways activated by vasoactive hormones to effect vasoconstriction or vasodilation. And ion channels are often targeted by therapeutic agents either intentionally (e.g. calcium channel blockers used to induce vasodilation and lower blood pressure) or unintentionally (e.g. to induce unwanted cardiovascular side effects). Kv7 (KCNQ) voltage-activated potassium channels have recently been implicated as important physiological and therapeutic targets for regulation of smooth muscle contraction. To elucidate the specific roles of Kv7 channels in both physiological signal transduction and in the actions of therapeutic agents, we need to study how their activity is modulated at the cellular level as well as evaluate their contribution in the context of the intact artery. The rat mesenteric arteries provide a useful model system. The arteries can be easily dissected, cleaned of connective tissue, and used to prepare isolated arterial myocytes for patch clamp electrophysiology, or cannulated and pressurized for measurements of vasoconstrictor/vasodilator responses under relatively physiological conditions. Here we describe the methods used for both types of measurements and provide some examples of how the experimental design can be integrated to provide a clearer understanding of the roles of these ion channels in the regulation of vascular tone.
阻力动脉壁内平滑肌细胞的收缩或舒张决定了动脉直径,从而控制通过血管的血流,并影响全身血压。收缩过程主要由胞质钙浓度(Ca(2+))调节,而胞质钙浓度又受多种离子转运体和通道的控制。离子通道是血管活性激素激活的信号转导通路中常见的中间介质,可导致血管收缩或舒张。离子通道常常是治疗药物的作用靶点,这些药物有的是有意为之(如用于诱导血管舒张和降低血压的钙通道阻滞剂),有的则是无意造成(如引发不良心血管副作用)。Kv7(KCNQ)电压激活钾通道最近被认为是调节平滑肌收缩的重要生理和治疗靶点。为了阐明Kv7通道在生理信号转导和治疗药物作用中的具体作用,我们需要研究其在细胞水平上的活性是如何被调节的,以及评估它们在完整动脉环境中的作用。大鼠肠系膜动脉提供了一个有用的模型系统。这些动脉易于解剖,去除结缔组织,可用于制备分离的动脉肌细胞进行膜片钳电生理学研究,或插管并加压以测量在相对生理条件下的血管收缩/舒张反应。在这里,我们描述了用于这两种测量类型的方法,并提供了一些示例,说明如何整合实验设计以更清楚地了解这些离子通道在血管张力调节中的作用。